Actively Recruiting
Early Experience Comparing Microfabricated Microcatheter and Guidewire to Surgeon-Selected Devices in Middle Meningeal Artery Embolization for Chronic Subdural Hematoma
Led by Ohio State University · Updated on 2026-01-07
100
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of a matched pair Aristotle 14 Guidewire and Plato Microcatheter compared to surgeons preference devices in middle meningeal artery MMA embolization treatment for patients with chronic subdural hematoma. The study aims to assess the function of these devices during the embolization procedure for this condition. This early experience study is conducted at a single center to understand potential differences in device performance. Participants will be randomly assigned with equal chance to one of two groups. One group will undergo the embolization procedure using the study devices matched pair Aristotle and Plato, while the other group will have the procedure performed using the devices chosen by their surgeon. The procedure and follow-up are part of standard medical care, so participation does not require extra time or effort beyond usual treatment. During the study, researchers will measure total navigation and procedure time, final embolization grades, incidence of adverse events at the time of surgery, and the rate of hemorrhage recurrence over two years. Participants progress will be monitored through standard care visits without additional burden. The study is sponsored by Ohio State University and will run until July 2029.
CONDITIONS
Brief Title
Microfabricated Microcatheter Advantages in Middle Meningeal Artery Embolization: an Early Experience at a Single Center
Research Team
E
Edouard Belizaire
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here